Immune Regulation News 1.04, November 6, 2009. Click here if you are unable to see images in this e-mail.

TOP STORIES

Study Reveals a 'Missing Link' in Immune Response to Disease
When a T cell's "receptors" lock onto antigens on the surface of a diseased cell, parts of the receptors bend in a way that signals the T cell to change from disease-scanning to disease-fighting mode, the researchers report. [Dana-Farber Cancer Institute, Boston]

Request A Poster  
Isolate Untouched Cells for
Antigen Processing and Presentation
with EasySep®
 
 
REQUEST A POSTER STEMCELL Technologies Inc
 



SCIENCE NEWS

New Genetic Cause of a Fatal Immune Disorder
Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, fatal, immune disorder characterized by uncontrolled activation of lymphocytes and macrophages. Scientists have now determined that two distinct mutations in the gene that generates syntaxin-binding protein 2 can cause disease in a subset of patients with FHL. [INSERM U768, Paris]

Fruit Fly Model Created to Help Unravel Genetics of Human Diabetes
In research published in the Proceedings of the National Academy of Sciences, researchers describe how they altered genes in fruit flies to model the loss of insulin production, as seen in human Type 1 diabetes. [Researchers at the University of Maryland, College Park]

NegSelRosetteSep_645x110_v01




CURRENT PUBLICATIONS

Adoptive Therapy with Redirected Primary Regulatory T Cells Results in Antigen-Specific Suppression of Arthritis
Scientists tested the ability of antigen-specific Tregs generated by retroviral gene transfer to ameliorate arthritis through linked suppression and therefore without cognate recognition of the disease-initiating antigen. [PNAS]

Wild-Type FOXP3 is Selectively Active in CD4+CD25hi Regulatory T Cells of Healthy Female Carriers of Different FOXP3 Mutations
Data demonstrate that expression of wild-type FOXP3 is indispensable for the presence of a normal nTreg compartment and suggest that FOXP3 is not necessary for effector T-cell differentiation in humans. [Blood]

Lymph Node Stromal Cells Support Dendritic Cell-Induced Gut-Homing of T Cells
Researchers demonstrate that mesenteric lymph node stromal cell-derived retinoic acid can directly induce the expression of gut-homing molecules on proliferating T cells, a process strongly enhanced by bone marrow-derived dendritic cells in vitro. [J Immunol]

Reduced Diabetes in BTK-Deficient Nonobese Diabetic Mice and Restoration of Diabetes with Provision of an Anti-Insulin IgH Chain Transgene
Type 1 diabetes results from T cell-mediated destruction of insulin-producing beta-cells. Although elimination of B lymphocytes has proven successful at preventing disease, modulation of B cell function as a means to prevent type 1 diabetes has not been investigated. [J Immunol]

Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF-Beta-Producing CD8+ Treg Cells Are Associated with Immunological Remission of Lupus
In posttransplant patients, both CD4+CD25highFoxP3+ and an unusual CD8+FoxP3+ Treg subset return to levels seen in normal subjects; accompanied by almost complete inhibition of pathogenic T cell response to critical peptide autoepitopes from histones in nucleosomes, the major lupus autoantigen from apoptotic cells. [J Immunol]

Chronic CD70-Driven Costimulation Impairs IgG Responses by Instructing T Cells to Inhibit Germinal Center B Cell Formation through FasL-Fas Interactions
CD70 provides costimulation that enhances effector T cell differentiation upon binding of its receptor, CD27. During chronic immune activation, CD70 is constitutively expressed on activated immune cells, and this induces T cell-driven disruption of neutralizing antibody responses via an unknown mechanism. [J Immunol]

Book A Demo  
Isolate Cells Directly from
Leukapheresis Products
with the "Easy 50" EasySep® Magnet
 
 
BOOK A DEMO STEMCELL Technologies Inc
 




INDUSTRY NEWS

FDA Clears SQI's Automated SQiDworks Diagnostics Platform and IgXPLEX Rheumatoid Arthritis Assay for Sale in the United States
SQI Diagnostics Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.

Virdante Pharmaceuticals Boosts First Round to $47M
Virdante Pharmaceuticals Inc. reports it has raised new funding to bring its Series A round to $47.75 million, to continue development of antibody-based drugs that have better anti-inflammatory activity, to better treat autoimmune and inflammatory disorders.

Phase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes Patients
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced plans to initiate an investigator sponsored Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients.

Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of Benlysta ™ in Systemic Lupus Erythematosus
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that BENLYSTA™ (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus.  


POLICY NEWS

NIAID Announces New Human Immunology Research Awards to Help Fight Emerging Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.



EVENTS

Autumn Immunology Conference 2009
November 20-23, 2009
Chicago, IL, USA

2009 Australasian Society for Immunology Meeting
December 6-10, 2009
Gold Coast, Australia

9th International Conference on New Trends in Immunosuppression and Immunotherapy
February 4-7, 2010
Prague, Czech Republic

13th International Conference on Lymphocyte Activation and Immune Regulation: Inflammasome and Inflammation
February 5-7, 2010
Newport Beach, California, USA

Keystone Symposium: Tolerance and Autoimmunity
February 16-21, 2010
Taos, New Mexico, USA

World Immune Regulation Meeting-IV
March 29-April 01, 2010
Davos, Switzerland

IMMUNOLOGY 2010
May 7-11, 2010
Baltimore, Maryland, USA

14th International Congress of Immunology
August 22-27, 2010
Kobe, Japan

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


JOB OPPORTUNITIES

Manager, Market Segment Regenerative Medicine (Sigma-Aldrich Corporation)

Technical Specialist (AABB)

R&D Scientist (STEMCELL Technologies)

Technical Support Representative - France (STEMCELL Technologies)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.


Have we missed an important article or publication in Immune Regulation News? Click here to submit!

 
forwardafriendicon